Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea

Korean J Intern Med. 2018 Mar;33(2):256-276. doi: 10.3904/kjim.2018.036. Epub 2018 Feb 27.

Abstract

Hematopoietic stem cell transplantation (HSCT) is a treatment for hematologic malignancies, immune deficiencies, or genetic diseases, ect. Recently, the number of HSCTs performed in Korea has increased and the outcomes have improved. However, infectious complications account for most of the morbidity and mortality after HSCT. Post-HSCT infectious complications are usually classified according to the time after HSCT: pre-engraftment, immediate post-engraftment, and late post-engraftment period. In addition, the types and risk factors of infectious complications differ according to the stem cell source, donor type, conditioning intensity, region, prophylaxis strategy, and comorbidities, such as graft-versushost disease and invasive fungal infection. In this review, we summarize infectious complications after HSCT, focusing on the Korean perspectives.

Keywords: Hematopoietic stem cell transplantation; Immunocompromised host; Infectious diseases; Opportunistic infections.

Publication types

  • Review

MeSH terms

  • Bacterial Infections / etiology*
  • Bacterial Infections / microbiology
  • Forecasting
  • Genetic Diseases, Inborn / therapy
  • Graft vs Host Disease
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Immune System Diseases / therapy
  • Immunocompromised Host
  • Mycoses / etiology*
  • Mycoses / microbiology
  • Postoperative Complications / classification*
  • Republic of Korea
  • Risk Factors
  • Transplantation Conditioning
  • Virus Diseases / etiology*
  • Virus Diseases / virology